TPCW
WGSWW

TD Private Client Wealth’s GeneDx Holdings Warrant WGSWW Stock Holding History

TD Private Client Wealth’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-400
Closed -$64 – 1483
2024
Q4 		$64 Hold
400
– – ﹤0.01% 1303
2024
Q3 		$30 Hold
400
– – ﹤0.01% 1275
2024
Q2 		$12 Hold
400
– – ﹤0.01% 1215
2024
Q1 		$22 Hold
400
– – ﹤0.01% 1214
2023
Q4 		$4 Hold
400
– – ﹤0.01% 1217
2023
Q3 		$12 Buy
+400
New +$11 ﹤0.01% 1211

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

TD Private Client Wealth's WGSWW Position: Q1 2025 in Review

TD Private Client Wealth sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2025, closing a stake of 400 shares — an estimated $64 sold.

TD Private Client Wealth first reported a position in WGSWW in Q3 2023 and held it in 6 quarters. The position peaked at $64 in Q4 2024. 14 funds tracked by Wall St. Rank hold WGSWW as of Q1 2025.

  • TD Private Client Wealth reported no remaining GeneDx Holdings Warrant position as of Q1 2025 after selling out during the quarter.
  • TD Private Client Wealth sold 400 GeneDx Holdings Warrant shares in Q1 2025, an estimated $64.
  • TD Private Client Wealth first reported a position in GeneDx Holdings Warrant in Q3 2023 and held it in 6 quarters.
  • TD Private Client Wealth's GeneDx Holdings Warrant position peaked at $64 in Q4 2024.
  • 14 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2025.

Based on TD Private Client Wealth's 13F filing for Q1 2025, filed 29 Apr 2025.